Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. RemeGen Co., Ltd.
  6. News
  7. Press Releases
    9995   CNE1000048G6

REMEGEN CO., LTD.

(9995)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-08-18 am EDT
50.00 HKD   -2.25%
08/03RemeGen to Purchase $4.4 Million of Wealth Management Products
MT
07/22RemeGen to Purchase Wealth Management Products from Qingdao Bank for $11.8 Million
MT
07/05RemeGen Invests $14 Million in Wealth Management Products
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société REMEGEN CO., LTD.
2021REMEGEN : Announcement regarding h share full circulation listing approval granted by the ..
PU
2021REMEGEN : (1) proposed issue of a shares and listing on the sci-tech board and other ancil..
PU
2021REMEGEN : Notice of the 2021 first class meeting of h shareholders
PU
2021REMEGEN : Proxy form for use at the 2021 first class meeting of h shareholders
PU
2021REMEGEN : Proxy form for use at the 2021 first class meeting of domestic shareholders and ..
PU
2021REMEGEN : Notice of the 2021 first class meeting of domestic shareholders and unlisted for..
PU
2021REMEGEN : Notice of the 2021 second extraordinary general meeting
PU
2021REMEGEN : Proxy form for use at the 2021 second extraordinary general meeting
PU
2021REMEGEN : Proposed issue of a shares and listing on the sci-tech board and other ancillary..
PU
2021REMEGEN : Connected transaction in relation to acquisition of assets
PU
2021REMEGEN : Notice of 2020 annual general meeting
PU
2021REMEGEN : Clarification announcement relating to the 2020 results announcement
PU
2021REMEGEN : Closure of register of members for 2020 annual general meeting and 2021 second e..
PU
2021REMEGEN : Inside information announcement - approval by the csrc of the application in res..
PU
2021REMEGEN : Poll results of the 2021 first extraordinary general meeting
PU
2021REMEGEN : Inside information announcement - national medical products administration grant..
PU
2021REMEGEN : Proxy form for use at the 2021 first extraordinary general meeting
PU
2021REMEGEN : Notice of 2021 first extraordinary general meeting
PU
2021REMEGEN : (1) proposed adoption of the first h share award and trust scheme; (2) proposed ..
PU
Analysis
China's biotech sector comes of age with big licensing deals, global ambitions
Upcoming sector events
10/27/22GILEAD SCIENCES, INC. : Q3 2022 Earnings Release (Projected)
11/02/22VERTEX PHARMACEUTICALS INCORPORATED : Q3 2022 Earnings Release (Projected)
11/03/22WUXI APPTEC CO., LTD. : Q3 2022 Earnings Release (Projected)
11/07/22BIONTECH SE : Q3 2022 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs